Umakanthan Jayadev Manikkam, Lunning Mathew A
Division of Hematology & Oncology, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, 986840, Nebraska Medical Center, Omaha, NE 68198-7680, United States.
Division of Hematology & Oncology, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, 986840, Nebraska Medical Center, Omaha, NE 68198-7680, United States.
Best Pract Res Clin Haematol. 2018 Mar;31(1):23-30. doi: 10.1016/j.beha.2017.10.004. Epub 2017 Nov 1.
Follicular lymphoma is the most common indolent non-Hodgkin lymphoma. Advanced stage disease is common at diagnosis. The timing of treatment for follicular lymphoma is best approached by considering the combination of presence or absence of symptoms along with estimation of tumor burden. Upfront treatment strategies should take into initial presentation variables, pace of disease progression and goals of care after discussion with the patient. Treatment approaches remain diverse and patient discernment is paramount.
滤泡性淋巴瘤是最常见的惰性非霍奇金淋巴瘤。晚期疾病在诊断时很常见。滤泡性淋巴瘤的治疗时机最好通过综合考虑有无症状以及评估肿瘤负荷来确定。一线治疗策略应考虑初始表现变量、疾病进展速度以及在与患者讨论后的护理目标。治疗方法仍然多种多样，患者的辨别能力至关重要。
